Astrazeneca

FromAstraZeneca ([email protected])
Sent withMailchimp
Subject (41)Truqap approved in US for prostate cancer
Preheader (138)Truqap combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer
Typography
Arial
Colors
Text Analysis
Body Words147
Subject Words7
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px788 px
X-Spam Score-0.5
Preheader OptimizedNo
Timing
Day of WeekThursday
TimeOvernight

Truqap approved in US for prostate cancer

Truqap combination approved in the US as first and only targeted treatment for PTEN-deficient metastatic hormone-sensitive prostate cancer
Truqap approved in US for prostate cancer